Last reviewed · How we verify

NCT04987879: AMPED

NASH AMPK Exercise Dosing (AMPED) Trial

Recruiting now NA Last updated 14 October 2025
What this trial tests

NA trial testing Exercise in NAFLD in 45 participants. Currently enrolling.

Timeline
30 August 2022
Primary endpoint
31 May 2026
15 July 2026

Quick facts

Lead sponsorMilton S. Hershey Medical Center
PhaseNA
StatusRecruiting now
Study typeINTERVENTIONAL
Allocationrandomized
Designparallel
Maskingnone
Primary purposetreatment
Enrollment45
Start date30 August 2022
Primary completion31 May 2026
Estimated completion15 July 2026
Sites1 location across United States

Drugs / interventions tested

Conditions studied

Sponsor

Milton S. Hershey Medical Center

Who can join

Adults 18 to 69, any sex, with NAFLD. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

There is no known cure or regulatory agency approved drug therapy for nonalcoholic fatty liver disease (NAFLD), the leading cause of liver disease worldwide, and its progressive type, NASH. This places increased importance on using exercise to treat NAFLD. While physical activity is recommended for all with NAFLD, how to best prescribe exercise as a specific treatment remains unknown, including what dose of exercise is most effective.

Publications & conference data

1 peer-reviewed publication reference this trial (live from Europe PMC):

  1. AMPED study: Protocol for a randomized controlled trial of different doses of aerobic exercise training.
    Stine JG, Hummer B, Smith N, Tressler H, et al · · 2024 · PMID 38896071 · DOI 10.1097/hc9.0000000000000464

Verify or expand the search:

Other trials of Exercise

Trials testing the same drug.

Other recruiting trials for NAFLD

Currently open trials in the same condition.

Other Milton S. Hershey Medical Center trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT04987879.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing